To establish the parsimonious model for blood glucose monitoring in patients with type 2 diabetes receiving oral hypoglycemic agent treatment.One hundred and fifty-nine adult Chinese type 2diabetes patients were randomized to receive rapid-acting or sustained-release gliclazide therapy for 12 weeks.Their blood glucose levels were measured at 10 time points in a 24 h period before and after treatment,and the 24 h mean blood To establish the parsimonious model for blood glucose monitoring in patients with type 2 diabetes receiving oral hypoglycemic agent treatment. One hundred and fifty-nine adult Chinese type 2 diabetes patients were randomized to receive rapid-acting or sustained-release gliclazide therapy for 12 weeks. Their blood glucose levels were measured at 10 time points in a 24 h period before and after treatment, and the 24 h mean blood